According to the National Breast Cancer Foundation audit of June 30, 2025 (Note 6, Contributions of Nonfinancial Assets): The Foundation received contributions of nonfinancial assets during fiscal 2025 on which it placed a total value of $11,643,475. [Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.] |
According to the National Breast Cancer Foundation audit of June 30, 2025 (Note 9, Concentrations of Credit and Market Risk): "...During the year ended June 30, 2025, the Organization received approximately 97% of total grants from one donor." |
According to the National Breast Cancer Foundation audit of June 30, 2025 (Note 10, Related Party Transactions): "During the years ended June 30, 2025 and 2024, the Organization awarded Patient Relief and Patient Navigator Program Grants in the amounts of $200,000 and $292,418, respectively, to a hospital for which a member of the board of directors is also a director. During the years ended June 30, 2025 and 2024, the Organization received donations consisting of financial and nonfinancial assets from employees and board members totaling $7,265 and $2,769, respectively. During the years ended June 30, 2025 and 2024, the Organization engaged in a partnership with another organization offering outreach services totaling $8,000 and $110,000, respectively. The president of the partnering organization is a member of the board of directors. The Chief Executive Officer and Chief Operating Officer/President for the Organization are related. Management believes the terms of the related party transactions for employment are more favorable to the Organization than could be attained from non-affiliated parties."
According to the National Breast Cancer Foundation (NBCF) tax filing for the fiscal year ended June 30, 2025: "The President/COO is the son of the CEO" (IRS Form 990, Schedule O re: Part VI, Section A, line 2). [The reported total compensation in calendar year 2024 for the CEO, Janelle Hail, and President/COO, Kevin Hail, is $328,547 and $294,298, respectively (IRS Form 990, Schedule J, Part II).] |
According to the National Breast Cancer Foundation tax filing for the fiscal year ended June 30, 2025, the Foundation reports re: Compensation, Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (IRS Form 990, Schedule J, Part II): The Foundation reports providing "bonus & incentive compensation" during 2024 to seven individuals. Janelle Hail, CEO, received $26,080 of bonus and incentive compensation with total reported compensation of $328,547. The remaining six individuals received between $12,641and $23,424 with total reported compensation ranging from $165,643 to $294,298. |